Stars of the Brain: Uncovering the Complexity of Astrocytes
- 22 hours ago
- 8 min read
Author: Alyssa Lee
Editor: Keoni Andrews
Introduction
When you picture a brain cell, a "neuron" is likely what comes to mind. Historically, neurons have dominated the spotlight within neuroscience research. However, these famous cells would be unable to function without the presence of the "stars of the brain"- astrocytes. Astrocytes are the most populous macroglia in the central nervous system (CNS). Following their initial discovery by Rudolf Virchow in 1858, they were viewed as mere support staff, playing passive roles in supporting neuronal function. Recent advancements have radically redefined these macroglia. Today, astrocytes are recognised as necessary regulators of CNS health, playing active roles in synapse regulation, information processing within neuronal circuits and the formation/maintenance of the blood brain barrier (BBB) (Gradisnik & Velnar, 2023; Sofroniew & Vinters, 2010). The multifunctional behaviour of these cells have earned them the label of the ‘housekeepers’ of the CNS as they play vital roles in both physiological homeostasis and the immune response in pathological states (Verkhratsky et al., 2021).
When the Stars Dim: Astrocytes dysfunction
Astrocytes are vital for overall CNS health. When they become dysfunctional or enter a state of prolonged reactivity, they actively contribute to the development and progression of various neurological or neuropsychiatric disorders.
In neurodegenerative diseases such as Alzheimer’s disease (AD), initially astrocytes attempt to protect the brain by assisting in amyloid-beta plaque clearance. However, after prolonged activity, they transform into a reactive, proinflammatory phenotype, producing cytokines that exacerbate disease progression (Kim et al., 2026; Kim et al., 2024). Restoring normal astrocytic function has been shown to help in the recovery of neuronal hyperactivity in AD, highlighting these cells as a major therapeutic target (Shah et al., 2022).
The health of astrocyte populations are also critical in neuropsychiatric contexts. Lima et al. (2014), modelled astrocyte pathology by poisoning astrocytes in the prefrontal cortex using an astrocyte specific toxin. Resulting in a decrease of astrocyte density, manifesting as schizophrenia-like cognitive symptoms, such as impaired working memory.
These examples highlight the importance astrocytes have in the CNS and how without their proper functioning issues arise.
A Tale of Two Matter Types: Astrocyte Heterogeneity
Astrocytes are complex cells and are highly heterogeneous on a morphological, genetic and functional level (Holt, 2023). A key part of this complexity is their spatial organisation, allowing them to carry out highly specialised, region-specific functions, a trait mapped as early as the prenatal stage (Schroeder et al., 2025). Traditionally, astrocytes can be classified into two basic morphological subtypes based on their neuroanatomical location: protoplasmic astrocytes and fibrous astrocytes, found in Fig 1 (Miller & Raff, 1984).
Table 1. A summary of Protoplasmic and Fibrous Astrocytes, highlighting their Location, Morphology and Primary Role.
| Protoplasmic Astrocytes | Fibrous astrocytes |
Location | Gray Matter (GM) | White Matter (WM) |
Morphology | Central soma. “Bushy” appearance, highly branched with primary and secondary/tertiary processes | Soma to one side. Straight, non-branched processes ending in small projections |
Primary Role | Regulating neurotransmission, maintaining the BBB, CNS homeostasis | Production and maintenance of the myelin sheath |

Figure 1. Tracings of protoplasmic and fibrous astrocytes. Protoplasmic astrocytes are highly branched with primary and secondary processes (branches), which split into many terminal processes (leaflets). Fibrous astrocytes are less branched with only primary processes that split into perinodal processes. The soma of protoplasmic astrocytes are found within the centre of the cell whereas the soma of fibrous astrocytes are found more towards the left with the length of the primary processes extending to the right.
Image by Verkhratsky et al. (2021)
Protoplasmic astrocytes and neurotransmission
Found widely distributed in the gray matter, protoplasmic astrocytes are critical for regulating synaptic transmission (Corkrum et al., 2020; Liu et al., 2021). Their endfeet ensheaths the synaptic terminals of neurons, forming the "tripartite synapse", a physiological model allowing bidirectional communication between the astrocyte and the pre- and post-synaptic neurons, shown in Fig 2.
Through the tripartite synapse, protoplasmic astrocytes actively regulate neurotransmitters, such as glutamate. While essential for normal brain processing and neuroplasticity, excess glutamate can cause excitotoxicity (de Ceglia et al., 2023; Pal, 2021). To prevent this, astrocytes express specialized membrane transporters (EAAT1 and EAAT2) that sweep up excess glutamate, degrade it into glutamine, and release it back for neuronal reuse (Adermark et al., 2022), shown in Fig 2. The reuptake and recycling cycle is vital as a disruption of neurotransmitter homeostasis, such as an excess in glutamate can lead to excessive Ca2+ influx in the postsynaptic neuron causing extreme neuronal firing and excitotoxicity (Teleanu et al., 2022).
Beyond simple uptake, they also actively release gliotransmitters, including glutamate, D-serine and ATP via Ca2+ regulated exocytosis to influence cognitive processing and synaptic plasticity (Harada et al., 2015; Sahlender et al., 2014). Furthermore, their endfeet enclose capillaries in the brain to form the outermost layer of the blood brain barrier (BBB), which allows them to regulate blood flow aligned with synaptic demand (Chiareli et al., 2021).
Fibrous astrocytes and myelination
In contrast, fibrous astrocytes populate the white matter (WM). Although currently less researched than their gray matter (GM) counterparts, current evidence identifies them as key regulators of the production and maintenance of the myelin sheath. Their perinodal processes communicate with the nodes of Ranvier and interact with myelinating oligodendrocytes along the white matter tracks, facilitating the production and maintenance of myelin to actively support neuronal connectivity (Sofroniew & Vinters, 2010; Stogsdill et al., 2023). Additionally, astrocytes secrete promyelinating factors and regulate the maturation and migration of oligodendrocyte progenitor cells (Molina-Gonzalez & Miron, 2019), allowing for the proper development of myelin.
Dynamic Responses to Brain Injury
Astrocyte heterogeneity is not only apparent in their different functions but also in their response to neuroplasticity - changes in the brain. Astrocyte heterogeneity also dictates how the brain heals. During recovery from an ischemic stroke, gray matter astrocytes induce angiogenesis (new blood vessel formation), while white matter astrocytes do not (Gleichman et al., 2025). Furthermore, mechanical injury causes fibrous astrocytes to simplify their structures, while protoplasmic astrocytes do the opposite, becoming increasingly complex and branched (Sun & Jakobs, 2012).

Figure 2. A diagram of the tripartite synapse (pre- and post-synaptic neuron and astrocyte) illustrating how astrocytes regulate glutamate neurotransmission. Glutamate (brown circles) is released in vesicles from the presynaptic terminal via exocytosis. The glutamate receptor on the astrocytes sense an excess of glutamate in the extrasynaptic space which triggers the reuptake of glutamate via express glutamate transporters excitatory amino acid transporter 1 (EAAT1) and transporters excitatory amino acid transporter 2 (EAAT2). The rest of the glutamate is taken up by the postsynaptic neuron. Glutamate taken up by the astrocyte is degraded into glutamine and released into the extrasynaptic space for neuronal uptake. Created using BioRender
Heterogeneity within GM and WM brain regions
The complexity deepens when looking within these broad categories. White matter astrocytes can be further divided by gene expression, as some are dedicated to axonal support, while others focus on cell proliferation (Bocchi et al., 2025). Similarly, gray matter astrocytes exhibit laminar specificity, displaying distinct shapes and genetic profiles depending on their specific layer within the neocortex (Lanjakornsiripan et al., 2018).
Conclusion
Taken together, research has revealed astrocytes are far from simple support units but are a diverse, highly specialised population of cells vital for CNS health and neural mechanisms. As GM and WM astrocytes govern different brain functions and respond uniquely to neurological insults, studying them as distinct populations is essential. Moving forward, continued research into astrocyte heterogeneity, particularly the under-explored WM populations, is imperative for developing targeted therapeutics that can prevent astrocytes from losing their protective mechanisms during disease or prevent their dysfunction/loss.
REFERENCES
Adermark, L., Lagström, O., Loftén, A., Licheri, V., Havenäng, A., Loi, E. A., Stomberg, R., Söderpalm, B., Domi, A., & Ericson, M. (2022). Astrocytes modulate extracellular neurotransmitter levels and excitatory neurotransmission in dorsolateral striatum via dopamine D2 receptor signaling. Neuropsychopharmacology, 47(8), 1493–1502. https://doi.org/10.1038/s41386-021-01232-x
Bocchi, R., Thorwirth, M., Simon-Ebert, T., Koupourtidou, C., Clavreul, S., Kolf, K., Della Vecchia, P., Bottes, S., Jessberger, S., Zhou, J., Wani, G., Pilz, G. A., Ninkovic, J., Buffo, A., Sirko, S., Götz, M., & Fischer-Sternjak, J. (2025). Astrocyte heterogeneity reveals region-specific astrogenesis in the white matter. Nat Neurosci, 28(3), 457–469. https://doi.org/10.1038/s41593-025-01878-6
Chiareli, R. A., Carvalho, G. A., Marques, B. L., Mota, L. S., Oliveira-Lima, O. C., Gomes, R. M., Birbrair, A., Gomez, R. S., Simão, F., Klempin, F., Leist, M., & Pinto, M. C. X. (2021). The Role of Astrocytes in the Neurorepair Process [Review]. Frontiers in Cell and Developmental Biology, Volume 9 - 2021. https://doi.org/10.3389/fcell.2021.665795
Corkrum, M., Covelo, A., Lines, J., Bellocchio, L., Pisansky, M., Loke, K., Quintana, R., Rothwell, P. E., Lujan, R., Marsicano, G., Martin, E. D., Thomas, M. J., Kofuji, P., & Araque, A. (2020). Dopamine-Evoked Synaptic Regulation in the Nucleus Accumbens Requires Astrocyte Activity. Neuron, 105(6), 1036–1047.e1035. https://doi.org/10.1016/j.neuron.2019.12.026
de Ceglia, R., Ledonne, A., Litvin, D. G., Lind, B. L., Carriero, G., Latagliata, E. C., Bindocci, E., Di Castro, M. A., Savtchouk, I., Vitali, I., Ranjak, A., Congiu, M., Canonica, T., Wisden, W., Harris, K., Mameli, M., Mercuri, N., Telley, L., & Volterra, A. (2023). Specialized astrocytes mediate glutamatergic gliotransmission in the CNS. Nature, 622(7981), 120–129. https://doi.org/10.1038/s41586-023-06502-w
Gleichman, A. J., Kawaguchi, R., Rathbun, E. M., Sofroniew, M. V., & Carmichael, S. T. (2025). Regionally mapped astrocytic responses to cortical and white matter stroke show differential roles in astrocyte-induced vascular remodeling. Neuron, 113(24), 4178–4198.e4179. https://doi.org/https://doi.org/10.1016/j.neuron.2025.09.023
Gradisnik, L., & Velnar, T. (2023). Astrocytes in the central nervous system and their functions in health and disease: A review. World J Clin Cases, 11(15), 3385–3394. https://doi.org/10.12998/wjcc.v11.i15.3385
Harada, K., Kamiya, T., & Tsuboi, T. (2015). Gliotransmitter Release from Astrocytes: Functional, Developmental, and Pathological Implications in the Brain. Front Neurosci, 9, 499. https://doi.org/10.3389/fnins.2015.00499
Holt, M. G. (2023). Astrocyte heterogeneity and interactions with local neural circuits. Essays Biochem, 67(1), 93–106. https://doi.org/10.1042/ebc20220136
Kim, H. Y., Kim, S., Akaydin, A. N., Kim, S., Hyeon, S. J., Lee, J., & Ryu, H. (2026). The rise of astrocytes: are they guardians or troublemakers of the brain disorder? Experimental & Molecular Medicine, 58(2), 301–318. https://doi.org/10.1038/s12276-025-01627-6
Kim, J., Yoo, I. D., Lim, J., & Moon, J.-S. (2024). Pathological phenotypes of astrocytes in Alzheimer’s disease. Experimental & Molecular Medicine, 56(1), 95–99. https://doi.org/10.1038/s12276-023-01148-0
Lanjakornsiripan, D., Pior, B.-J., Kawaguchi, D., Furutachi, S., Tahara, T., Katsuyama, Y., Suzuki, Y., Fukazawa, Y., & Gotoh, Y. (2018). Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers. Nature Communications, 9(1), 1623. https://doi.org/10.1038/s41467-018-03940-3
Lima, A., Sardinha, V. M., Oliveira, A. F., Reis, M., Mota, C., Silva, M. A., Marques, F., Cerqueira, J. J., Pinto, L., Sousa, N., & Oliveira, J. F. (2014). Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats. Molecular Psychiatry, 19(7), 834–841. https://doi.org/10.1038/mp.2013.182
Liu, X., Ying, J., Wang, X., Zheng, Q., Zhao, T., Yoon, S., Yu, W., Yang, D., Fang, Y., & Hua, F. (2021). Astrocytes in Neural Circuits: Key Factors in Synaptic Regulation and Potential Targets for Neurodevelopmental Disorders. Front Mol Neurosci, 14, 729273. https://doi.org/10.3389/fnmol.2021.729273
Miller, R., & Raff, M. (1984). Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. The Journal of Neuroscience, 4(2), 585–592. https://doi.org/10.1523/jneurosci.04-02-00585.1984
Molina-Gonzalez, I., & Miron, V. E. (2019). Astrocytes in myelination and remyelination. Neuroscience Letters, 713, 134532. https://doi.org/https://doi.org/10.1016/j.neulet.2019.134532
Pal, M. M. (2021). Glutamate: The Master Neurotransmitter and Its Implications in Chronic Stress and Mood Disorders. Front Hum Neurosci, 15, 722323. https://doi.org/10.3389/fnhum.2021.722323
Sahlender, D. A., Savtchouk, I., & Volterra, A. (2014). What do we know about gliotransmitter release from astrocytes? Philos Trans R Soc Lond B Biol Sci, 369(1654), 20130592. https://doi.org/10.1098/rstb.2013.0592
Schroeder, M. E., McCormack, D. M., Metzner, L. R., Kang, J., Li, K. X., Yu, E., Melamed, L., Levandowski, K. M., Zaniewski, H., Zhang, Q., Boyden, E. S., Krienen, F. M., & Feng, G. (2025). A transcriptomic atlas of astrocyte heterogeneity across space and time in mouse and marmoset. Neuron, 113(23), 3942–3965.e3919. https://doi.org/10.1016/j.neuron.2025.09.011
Shah, D., Gsell, W., Wahis, J., Luckett, E. S., Jamoulle, T., Vermaercke, B., Preman, P., Moechars, D., Hendrickx, V., Jaspers, T., Craessaerts, K., Horré, K., Wolfs, L., Fiers, M., Holt, M., Thal, D. R., Callaerts-Vegh, Z., D'Hooge, R., Vandenberghe, R.,…De Strooper, B. (2022). Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer's disease. Cell Rep, 40(8), 111280. https://doi.org/10.1016/j.celrep.2022.111280
Sofroniew, M. V., & Vinters, H. V. (2010). Astrocytes: biology and pathology. Acta Neuropathol, 119(1), 7–35. https://doi.org/10.1007/s00401-009-0619-8
Stogsdill, J. A., Harwell, C. C., & Goldman, S. A. (2023). Astrocytes as master modulators of neural networks: Synaptic functions and disease-associated dysfunction of astrocytes. Annals of the New York Academy of Sciences, 1525(1), 41–60. https://doi.org/https://doi.org/10.1111/nyas.15004
Sun, D., & Jakobs, T. C. (2012). Structural remodeling of astrocytes in the injured CNS. Neuroscientist, 18(6), 567–588. https://doi.org/10.1177/1073858411423441
Teleanu, R. I., Niculescu, A. G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022). Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. Int J Mol Sci, 23(11). https://doi.org/10.3390/ijms23115954
Verkhratsky, A., Parpura, V., Li, B., & Scuderi, C. (2021). Astrocytes: The Housekeepers and Guardians of the CNS. Adv Neurobiol, 26, 21–53. https://doi.org/10.1007/978-3-030-77375-5_2


Comments